Literature DB >> 35006272

Structural Lesions on Kidney Biopsy in Youth-Onset and Adult-Onset Type 2 Diabetes.

Helen C Looker1, Laura Pyle2, Tim Vigers2, Cameron Severn2, Pierre J Saulnier3, Behzad Najafian4, Michael Mauer5, Robert G Nelson1, Petter Bjornstad2.   

Abstract

OBJECTIVE: Type 2 diabetes (T2D) is a leading cause of end-stage kidney disease worldwide. Recent studies suggest a more aggressive clinical course of diabetic kidney disease in youth-onset compared with adult-onset T2D. We compared kidney structural lesions in youth- and adult-onset T2D to determine if youth onset was associated with greater early tissue injury. RESEARCH DESIGN AND METHODS: Quantitative microscopy was performed on kidney tissue obtained from research kidney biopsies in 161 Pima Indians (117 women, 44 men) with T2D. Onset of T2D was established by serial oral glucose tolerance testing, and participants were stratified as youth onset (age <25 years) or adult onset (age ≥25 years). Associations between clinical and morphometric parameters and age at onset were tested using linear models.
RESULTS: At biopsy, the 52 participants with youth-onset T2D were younger than the 109 with adult-onset T2D (39.1 ± 9.9 vs. 51.4 ± 10.2 years; P < 0.0001), but their diabetes duration was similar (19.3 ± 8.1 vs. 17.0 ± 7.8 years; P = 0.09). Median urine albumin-to-creatinine ratio was higher in the youth-onset group (58 [25th-75th percentile 17-470] vs. 27 [13-73] mg/g; P = 0.02). Youth-onset participants had greater glomerular basement membrane (GBM) width (552 ± 128 vs. 490 ± 114 nm; P = 0.002) and mesangial fractional volume (0.31 ± 0.10 vs. 0.27 ± 0.08; P = 0.001) than adult-onset participants. Glomerular sclerosis percentage, glomerular volume, mesangial fractional volume, and GBM width were also inversely associated with age at diabetes onset as a continuous variable.
CONCLUSIONS: Younger age at T2D onset strongly associates with more severe kidney structural lesions. Studies are underway to elucidate the pathways underlying these associations.
© 2022 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2022        PMID: 35006272      PMCID: PMC8914414          DOI: 10.2337/dc21-1688

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  38 in total

1.  Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Authors:  Petter Bjornstad; Lori Laffel; Jane Lynch; Laure El Ghormli; Ruth S Weinstock; Sherida E Tollefsen; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2019-04-09       Impact factor: 19.112

2.  Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2019-06-09       Impact factor: 19.112

3.  Evolution of incipient nephropathy in type 2 diabetes mellitus.

Authors:  K V Lemley; I Abdullah; B D Myers; T W Meyer; K Blouch; W E Smith; P H Bennett; R G Nelson
Journal:  Kidney Int       Date:  2000-09       Impact factor: 10.612

Review 4.  Youth-Onset Type 2 Diabetes Manifestations in other Specialties: Its Many Disguises.

Authors:  Daniel Weghuber; Margarita Barrientos-Pérez; Margarita Kovarenko
Journal:  Ann Nutr Metab       Date:  2019-05-16       Impact factor: 3.374

5.  Podocyte loss and progressive glomerular injury in type II diabetes.

Authors:  M E Pagtalunan; P L Miller; S Jumping-Eagle; R G Nelson; B D Myers; H G Rennke; N S Coplon; L Sun; T W Meyer
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

6.  Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.

Authors:  Gudeta D Fufaa; E Jennifer Weil; Kevin V Lemley; William C Knowler; Frank C Brosius; Berne Yee; Michael Mauer; Robert G Nelson
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-20       Impact factor: 8.237

7.  Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

Authors:  Christoph Wanner; Silvio E Inzucchi; John M Lachin; David Fitchett; Maximilian von Eynatten; Michaela Mattheus; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Bernard Zinman
Journal:  N Engl J Med       Date:  2016-06-14       Impact factor: 91.245

8.  Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study.

Authors:  David M Maahs; Beverly M Snively; Ronny A Bell; Lawrence Dolan; Irl Hirsch; Giuseppina Imperatore; Barbara Linder; Santica M Marcovina; Elizabeth J Mayer-Davis; David J Pettitt; Beatriz L Rodriguez; Dana Dabelea
Journal:  Diabetes Care       Date:  2007-07-13       Impact factor: 19.112

9.  Long-Term Complications in Youth-Onset Type 2 Diabetes.

Authors:  Petter Bjornstad; Kimberly L Drews; Sonia Caprio; Rose Gubitosi-Klug; David M Nathan; Bereket Tesfaldet; Jeanie Tryggestad; Neil H White; Philip Zeitler
Journal:  N Engl J Med       Date:  2021-07-29       Impact factor: 91.245

Review 10.  Pima Indian Contributions to Our Understanding of Diabetic Kidney Disease.

Authors:  Robert G Nelson; William C Knowler; Matthias Kretzler; Kevin V Lemley; Helen C Looker; Michael Mauer; William E Mitch; Behzad Najafian; Peter H Bennett
Journal:  Diabetes       Date:  2021-07-20       Impact factor: 9.337

View more
  1 in total

1.  Dapagliflozin in young people with type 2 diabetes.

Authors:  Kalie L Tommerdahl; Robert G Nelson; Petter Bjornstad
Journal:  Lancet Diabetes Endocrinol       Date:  2022-04-01       Impact factor: 44.867

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.